Mixed signal: momentum 56/100, trend 50/100.
Prediction result · Ensemble engineUpdated 5:44 AM
NICENICE Ltd. stock price outlook
NICE Ltd. (NICE) is trading at $113.76, down 1.07% since the previous close and -6.12% over the past week. Price sits above its 50-day average by 2.81%, with price momentum at 56/100 and trend velocity at 50/100. Sentiment across 8 recent headlines reads mixed at 57/100. Volatility risk is moderate (65/100) and the stock is 55% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
NICE Ltd.
- NICE Ltd. (NICE) is trading at $113.76, down 1.07% since the previous close and -6.12% over the past week. Price sits above its 50-day average by 2.81%, with price momentum at 56/100 and trend velocity at 50/100. Sentiment across 8 recent headlines reads mixed at 57/100. Volatility risk is moderate (65/100) and the stock is 55% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
- Bull input: No bullish case in the sources.
- Bear input: No bearish case in the sources.
Signals are model output from public data, not personalized investment advice.
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · No edge
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
8 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
NICE Ltd. (NICE) is trading at $113.76, down 1.07% since the previous close and -6.12% over the past week. Price sits above its 50-day average by 2.81%, with price momentum at 56/100 and trend velocity at 50/100. Sentiment across 8 recent headlines reads mixed at 57/100. Volatility risk is moderate (65/100) and the stock is 55% of the way up its 52-week range. The weighted factor score lands at 50/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on NICE
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Sentiment 57/100 + price -1.1% are both mid-range.
Volume read 38/100 with price drift -1.1% — no clear footprint.
Vol regime 65/100 is mid-range — no edge.
Mid-range positioning — no edge from range alone.
Sentiment 57/100 vs week change -6.1% are in agreement — no divergence edge.
Price within 2.8% of the 50d SMA — no clear structural read.
Oscillator at 53 — neutral zone.
Momentum 56/100 is not strong enough to confirm a breakout.
News 57/100 and weekly change -6.1% do not create a clean follow-through read.
Volume 38/100 does not show a dry-up signal.
Volatility 65/100 does not give a clean compression read.
Range position 55% is too middle-of-the-road to matter.
Sentiment 57/100 and momentum 56/100 are not aligned enough for a clean read.
50d SMA distance 2.8% is not decisive.
Oscillator at 53 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 56/100, trend 50/100.
- Sentiment 57/100 + price -1.1% are both mid-range.
- Price within 2.8% of the 50d SMA — no clear structural read.
Bull Case
- No bullish case in the sources.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
Nice (NICE) stock declines while market improves: Some information for investors
4/8/2026, 2:50:00 PM
NICE Stock And 2 Software Names Tied To Crypto Compliance Growth
10/31/2026, 3:12:00 PM
NICE (TASE:NICE) Stock May Be 50% Undervalued Following AI Leadership Recognition
10/26/2026, 12:11:00 PM
Here is What to Know Beyond Why Nice (NICE) is a Trending Stock
10/9/2026, 5:00:03 AM
NICE: Earnings Should Continue To Grow Robustly
1/21/2025, 8:40:00 PM
Key stats
- Sector
- Technology
- Industry
- Computer Software: Prepackaged Software
- Market cap
- $6.76B
- 52-week range
- $138.58/$83.1
- Volume
- 518,971
- Avg volume
- 488,841
- Analyst 1-yr target
- $128.50
- Exchange
- NASDAQ-GS
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Nov 4, 2026
Estimate
$2.1
Actual
$1.95
- • Last report Aug 5, 2026 (Jun 2026): EPS $1.95 vs $2.13 expected, -8.45% surprise.
- • Beat estimates in 2 of the last 4 quarters.
- • Next report expected Nov 4, 2026, consensus EPS $2.1 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • High volatility — position sizing and stops matter more here.
- • Confirm liquidity, spreads, and your own thesis before acting.
NICE questions
What is the MarketPicks AI signal for NICE Ltd. stock (NICE)?
As of Nov 2, 12:44 AM ET, the ensemble reads neutral on NICE — no consensus — 16 of 16 bots holding, with 0 bull, 0 bear and 16 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest NICE price on MarketPicks?
NICE was $113.76 on the latest quote (Nov 2, 12:44 AM ET), -1.07% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for NICE mean?
Scores run from 0 to 100, with 50 neutral. NICE shows momentum 56/100, trend velocity 50/100 and volatility risk 65/100, with news sentiment at 57/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.